Regional variation in the use of implantable cardioverter-defibrillators for primary prevention results from the national cardiovascular data registry

Circulation: Cardiovascular Quality and Outcomes

Volumn 4, Issue 1, 2011, Pages 114-121

  Matlock, Dan D ^a,b   Peterson, Pamela N ^a,b,c,d   Heidenreich, Paul A ^e   Lucas, F Lee ^f   Malenka, David J ^g   Wang, Yongfei ^h   Curtis, Jeptha P ^h   Kutner, Jean S ^a   Fisher, Elliott S ^g   Masoudi, Frederick A ^a,b,c,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Colorado Cardiovascular Outcomes Research Group ^*  (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

^d KAISER PERMANENTE   (United States)

^e STANFORD UNIVERSITY   (United States)

^f MAINE MEDICAL CENTER   (United States)

^g DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^h YALE UNIVERSITY   (United States)

Author keywords

Implantable cardioverter defibrillators congestive heart failure regional variations

Indexed keywords

AGED; ARTICLE; CARDIOLOGIST; CROSS-SECTIONAL STUDY; DISEASE REGISTRY; ELECTROPHYSIOLOGIST; FEMALE; HEALTH CARE PERSONNEL; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT REFERRAL; PRIORITY JOURNAL; UNITED STATES; CLINICAL TRIAL (TOPIC); DEFIBRILLATOR; PRIMARY PREVENTION; REGISTER; SUDDEN DEATH;

AGED; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PRIMARY PREVENTION; REGISTRIES;

EID: 79953206006     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.110.958264     Document Type: Article

References (49)

1. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G, The Multicenter Unsustained Tachycardia Trial Investigators. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med. 2000;342:1937-1945 (Pubitemid 30419088)
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Comparison of medical therapy PaDiHFCI: cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883 (Pubitemid 34984635)
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Vidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237 (Pubitemid 40110811)
5. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implan-tation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158 (Pubitemid 38637995)
6. Centers for Medicare and Medicaid Services. Decision Memo for Implantable Defibrillators. Available at: http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp? id-148. 2009. Accessed April 24, 2009
7. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med. 2005;352:222-224 (Pubitemid 40110810)
8. Centers for Medicare and Medicaid Services. Coverage with Evidence Development. Available at: http://www.cms.gov/CoverageGenInfo/03-CED.asp. 2009 March 27. Accessed April 24, 2009
9. Wennberg DE, Birkmeyer JD, Birkmeyer NJO. The Dartmouth Atlas of Cardiovascular Health Care. Chicago: AHA Press; 1999
10. Groeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol. 2005;45:72-78 (Pubitemid 40052029)
11. Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC, Peterson ED, Get With The Guidelines Steering Committee. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure). J Am Coll Cardiol. 2009;53:416-422
12. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, Albert NM, Peterson ED. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298:1525-1532 (Pubitemid 47529386)
13. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverterdefibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007;298:1517-1524 (Pubitemid 47529385)
14. The American College of Cardiology. National Cardiovascular Data Registry. Available at: http://www.accncdr.com/webncdr/ICD/Default.aspx. 2007. Accessed November 29, 2009
15. Hammill SC, Stevenson LW, Kadish AH, Kremers MS, Heidenreich P, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Lang CM, Harder JC, Brindis RG. Review of the registry's first year, data collected, and future plans. Heart Rhythm. 2007;4:1260-1263 (Pubitemid 47324135)
16. Wennberg JE. The Dartmouth Atlas of Health Care 1999: The Quality of Medical Care in the United States. Chicago: AHA Press; 1999
17. The Dartmouth Atlas of Healthcare. Downloads. Available at: http://www.dartmouthatlas.org/data/download.shtm. 2009. Accessed April 25, 2009
18. AMA Physician Masterfile. Available at: http://www.ama-assn org/ama/pub/about-ama/physician-data-resources/physician-masterfile.shtml. 2009
19. Gordis L. Epidemiology. Amsterdam: Elsevier Science; 2004
20. Medicare: A Strategy for Quality Assurance. Washington DC: National Academy Press; 1990
21. The Dartmouth Atlas of Vascular Health Care. Chicago: American Heart Association; 1999
22. Centers for Medicare and Medicaid Services. Behavioral Risk Factor Surveillance System. http://apps nccd cdc gov/brfss/. 2008. Accessed July 7, 2009
23. Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA. 2009;301:1661-1670
24. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending: part 1, the content, quality, and accessibility of care. Ann Intern Med. 2003;138: 273-287 (Pubitemid 36205924)
25. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending: part 2, health outcomes and satisfaction with care Ann Intern Med. 2003;138: 288-298 (Pubitemid 36205925)
26. Shain M, Roemer MI. Hospital costs relate to the supply of beds. Modern Hosp. 1959;92:71-73
27. Fye WB. Cardiology's workforce shortage: implications for patient care and research. Circulation. 2004;109:813-816 (Pubitemid 38252728)
28. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1111-1121
29. Epstein AE. Benefits of the implantable cardioverter-defibrillator. J Am Coll Cardiol. 2008;52:1122-1127
30. Leape LL, Hilborne LH, Park RE, Bernstein SJ, Kamberg CJ, Sherwood M, Brook RH. The appropriateness of use of coronary artery bypass graft surgery in New York State. JAMA. 1993;269:753-760 (Pubitemid 23039081)
31. Hilborne LH, Leape LL, Bernstein SJ, Park RE, Fiske ME, Kamberg CJ, Roth CP, Brook RH. The appropriateness of use of percutaneous transluminal coronary angioplasty in New York State. JAMA. 1993;269: 761-765 (Pubitemid 23039082)
32. Bernstein SJ, Hilborne LH, Leape LL, Fiske ME, Park RE, Kamberg CJ, Brook RH. The appropriateness of use of coronary angiography in New York State. JAMA. 1993;10:269:766-769 (Pubitemid 23039083)
33. Hicks NR. Some observations on attempts to measure appropriateness of care. BMJ. 1994;309:730-733 (Pubitemid 24285233)
34. Phelps CE. The methodologic foundations of studies of the appropriateness of medical care. N Engl J Med. 1993;329:1241-1245 (Pubitemid 23306327)
35. Baicker K, Buckles KS, Chandra A. Geographic variation in the appropriate use of cesarean delivery. Health Aff. 2006;25:w355-w367 (Pubitemid 44497608)
36. Fowler FJ Jr, Gallagher PM, Anthony DL, Larsen K, Skinner JS. Relationship between regional per capita Medicare expenditures and patient perceptions of quality of care. JAMA. 2008;299:2406-2412 (Pubitemid 351749239)
37. Barnato AE, Herndon MB, Anthony DL, Gallagher PM, Skinner JS, Bynum JP, Fisher ES. Are regional variations in end-of-life care intensity explained by patient preferences? A study of the US Medicare population. Med Care. 2007;45:386-393
38. Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS, Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation. 2006;113:2810-2817 (Pubitemid 44305293)
39. Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H, Moss AJ, Dick AW, Multicenter Automatic Defibrillator Implantation Trial II: health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care. 2007;45:377-385
40. Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Vidson-Ray L, Lee KL, Bardy GH, the Sudden Cardiac Death in Heart Failure Trial Investigators. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med. 2008;359:999-1008
41. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart. 2002;87:488-493 (Pubitemid 34454597)
42. Sears SF Jr, Conti JB. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators. Am J Cardiol. 2006;98:565-567 (Pubitemid 44162889)
43. Washizuka T, Chinushi M, Kazama R, Hirono T, Watanabe H, Komura S, Sugiura H, Tanabe Y, Furushima H, Fujita S, Okura Y, Aizawa Y. Inappropriate discharges of intravenous implantable cardioverter defibrillators owing to lead failure. Int Heart J. 2005;46:909-913
44. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141:835-838 (Pubitemid 39601176)
45. O'Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, Tait V, Tetroe J, Fiset V, Barry M, Jones J. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2007;4
46. Lee JH, Chuu K, Spertus J, O'Keefe JH. Abstract 6224: Widespread patient misconceptions regarding the benefits of elective percutaneous coronary intervention (18 Meeting Abstracts). Circulation. 2008;118
47. Garrick CS, Joanne RW, Parakash PP, Marc JS, Janice MC, Kimberly B, Sui WT, Mary SA, Viviane TN, Eldrin FL, Anju N, Akshay S. Desai, MIael MG, Lynne WS. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail. 2010;16:106-113
48. Lorence D. Regional variation in medical classification agreement: benchmarking the coding gap. J Med Syst. 2003;27:435-443 (Pubitemid 38115302)
49. Lorence D, Chen L. Disparities in health information quality across the rural-urban continuum: where is coded data more reliable? J Med Syst. 2008;32:1-8